Vir Biotechnology, Inc. · NASDAQ:VIR

de Verneuil Vanina sold 3,750 Vir Biotechnology, Inc. shares (Form 4)

Traded Nov 2 to Nov 3, 2026 · Filed Nov 4, 2026

From Nov 2 to Nov 3, 2026, de Verneuil Vanina (EVP, General Counsel, Corp Sec) sold 3,750 Vir Biotechnology, Inc. shares at an average US$11.18 for US$41,939 under a trading plan, leaving 110,193 shares. Filed Nov 4, 2026 (Form 4).

Sold
3,750 shares
Price
US$11.18 average (US$11.10 to US$11.33)
Value
US$41,939
Holding after
110,193 shares
Trading plan
Yes (Made under a plan set in advance)
Role
EVP, General Counsel, Corp Sec

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Nov 2, 2026Common StockSale1,343US$11.33112,600Direct
Nov 3, 2026Common StockSale2,407US$11.10110,193Direct

Source

Download original · View original at SEC

Related